Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:55:50.207Z.
Calculation as of: 2026-10-06T14:55:50.207Z.
Quote observation: 2026-10-06T14:53:52.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b8bc85e2d5351a47333dd9131f39a7cf6b6d5f02586c5202dd123a5ad4370615
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Apyx Medical Corporation
Market Cap
$108.64M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.29M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.42M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.44M
Free Cash Flow Yield
N/A
TTM Avg
13.79%
3Y Avg
13.79%
5Y Avg
13.79%
Market Cap
$107.28M
Free Cash Flow Yield
N/A
TTM Avg
10.25%
3Y Avg
16.93%
5Y Avg
15.95%
Market Cap
$110.05M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.48M
Free Cash Flow Yield
27.08%
TTM Avg
25.60%
3Y Avg
13.86%
5Y Avg
9.06%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apyx Medical Corporation (APYX) | $108.64M | N/A | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.29M | N/A | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $109.42M | N/A | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.75M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | N/A | 13.79% | 13.79% | 13.79% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.28M | N/A | 10.25% | 16.93% | 15.95% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $110.05M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.48M | 27.08% | 25.60% | 13.86% | 9.06% |
| Coya Therapeutics, Inc. (COYA)vs › | $113.30M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
